依沃西+ADC联合治疗实体瘤2025年2月24日,Summit Therapeutics公布2024年财报,披露了研发管线最新进展,同时宣布与辉瑞达成临床合作,开展PD-1/VEGF依沃西+ADC联合治疗实体瘤的临床探索。相关的临床试验预计将在2025年年中启动。2022年12月,康方生物以5亿美元首付款、总交易额高达50亿美元和销售净额低双位数比例提成的合作方案,授予Summit ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.